Flow chemistry synthesis of zolpidem, alpidem and other GABAA agonists and their biological evaluation through the use of in-line frontal affinity chromatography

The flow of information between chemical and biological research can present a bottleneck in pharmaceutical research. Tools that bridge these disciplines and aid information exchange have therefore clear value. Over the last few years, both synthetic chemistry and biological screening have benefited from automation, and a seamless chemistry–biology interface is now possible. We report here on the use of flow processes to perform synthesis and biological evaluation in an integrated manner. As proof of concept, a flow synthesis of a series of imidazo[1,2-a]pyridines, including zolpidem and alpidem, was developed and connected to a Frontal Affinity Chromatography screening assay to investigate their interaction with Human Serum Albumin (HSA).

[1]  S. Ley,et al.  Solid Phase Synthesis of Bicyclo[2.2.2]octane Derivatives via Tandem Michael Addition Reactions and Subsequent Reductive Amination , 1995 .

[2]  V. Gevorgyan,et al.  General and efficient copper-catalyzed three-component coupling reaction towards imidazoheterocycles: one-pot synthesis of alpidem and zolpidem. , 2010, Angewandte Chemie.

[3]  J. Hirabayashi,et al.  Frontal affinity chromatography: sugar–protein interactions , 2007, Nature Protocols.

[4]  Ananda Herath,et al.  Fully automated continuous flow synthesis of highly functionalized imidazo[1,2-a] heterocycles. , 2010, Organic letters.

[5]  E. Domenici,et al.  Drug binding to human serum albumin: abridged review of results obtained with high-performance liquid chromatography and circular dichroism. , 2006, Chirality.

[6]  Leslie Y Yeo,et al.  Microfluidic devices for bioapplications. , 2011, Small.

[7]  Andreas Kirschning,et al.  Continuous flow techniques in organic synthesis. , 2003, Chemistry.

[8]  David C Schriemer,et al.  Frontal affinity chromatography-mass spectrometry assay technology for multiple stages of drug discovery: applications of a chromatographic biosensor. , 2003, Analytical biochemistry.

[9]  Steven V Ley,et al.  A fully automated, multistep flow synthesis of 5-amino-4-cyano-1,2,3-triazoles. , 2011, Organic & biomolecular chemistry.

[10]  Steven V Ley,et al.  The application of flow microreactors to the preparation of a family of casein kinase I inhibitors. , 2010, Organic & biomolecular chemistry.

[11]  K. Kasai,et al.  Quantitative analysis of affinity chromatography of trypsin. A new technique for investigation of protein-ligand interaction. , 1975, Journal of biochemistry.

[12]  M. Lancel,et al.  Sleep and Its Modulation by Drugs That Affect GABA(A) Receptor Function. , 1999, Angewandte Chemie.

[13]  G. Bianchetti,et al.  Plasma protein binding of alpidem in healthy volunteers, in neonates and in liver or renal insufficiency , 2004, European Journal of Clinical Pharmacology.

[14]  M. Abraham,et al.  Fast gradient HPLC method to determine compounds binding to human serum albumin. Relationships with octanol/water and immobilized artificial membrane lipophilicity. , 2003, Journal of pharmaceutical sciences.

[15]  J. Hirabayashi,et al.  Frontal affinity chromatography as a tool for elucidation of sugar recognition properties of lectins. , 2003, Methods in enzymology.

[16]  S. Ley,et al.  A flow process for the multi-step synthesis of the alkaloid natural product oxomaritidine: a new paradigm for molecular assembly. , 2006, Chemical communications.

[17]  Peter H Seeberger,et al.  Trimethylaluminium mediated amide bond formation in a continuous flow microreactor as key to the synthesis of rimonabant and efaproxiral. , 2008, Chemical communications.

[18]  D. Schriemer,et al.  Frontal affinity chromatography—mass spectrometry , 2007, Nature Protocols.

[19]  William Ng,et al.  Automated Multiple Ligand Screening by Frontal Affinity Chromatography–Mass Spectrometry (FAC-MS) , 2007, Journal of biomolecular screening.

[20]  G. Massolini,et al.  Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptor. , 2010, Journal of medicinal chemistry.

[21]  Steven V. Ley,et al.  The Changing Face of Organic Synthesis , 2008 .